Profile of:

Valeria Rios Rodriguez


Degree in Medicine from the University of Barcelona. Specialist in Rheumatology at Bellvitge University Hospital, where she also completed a residency and clinical fellowship. Research Fellowship in Early Diagnosis of Spondyloarthritis at the same institution under the guidance of Dr. Xavier Juanola, followed by a Clinical Research Fellowship in Spondyloarthritis and Imaging at Charité–Universitätsmedizin Berlin under Dr. Joachim Sieper. She also holds a Master’s degree in Microbiota, Probiotics, and Prebiotics from the European University of Madrid, focusing on intestinal dysbiosis in axial spondyloarthritis. Since 2014, she has combined clinical practice at the Charité CBF Outpatient Clinic—where she specializes in spondyloarthritis and psoriatic arthritis—with multiple leadership roles in clinical research, including serving as Head of the Research Unit in the Rheumatology Department during 2024. She has been recognized with the ASPIRE Rheumatology and Inflammatory Bowel Disease Research Award and a EULAR Abstract Award. She is a member of the German Society of Rheumatology (DGRh), the Assessment of SpondyloArthritis International Society (ASAS), and Young ASAS.

Full name: Valeria Rios Rodriguez

Current country: Germany

Membership level: Full

Type of membership: Member

Number of publications: 36

Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy (2025)
https://pubmed.ncbi.nlm.nih.gov/39762123/

Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapy (2024)
https://pubmed.ncbi.nlm.nih.gov/38507706/

Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial (2024)
https://pubmed.ncbi.nlm.nih.gov/38228361/

Comparing clinical profiles in spondyloarthritis with Crohn’s disease or ulcerative colitis: insights from the ASAS-PerSpA study (2024)
https://pubmed.ncbi.nlm.nih.gov/38807853/

Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/39740933/

Anatomical variation of the sacroiliac joint carries an increased risk for erosion and bone marrow oedema in axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/35532084/

Keep an Eye on the Back: Spondyloarthritis in Patients With Acute Anterior Uveitis (2023)
https://pubmed.ncbi.nlm.nih.gov/35905288/

Deep Learning Detects Changes Indicative of Axial Spondyloarthritis at MRI of Sacroiliac Joints (2023)
https://pubmed.ncbi.nlm.nih.gov/37093751/

Spondyloarthritis, acute anterior uveitis, and Crohn’s disease have both shared and distinct gut microbiota (2023)
https://pubmed.ncbi.nlm.nih.gov/37471465/

Presence of spondyloarthritis associated to higher disease activity and HLA-B27 positivity in patients with early Crohn’s disease: Clinical and MRI results from a prospective inception cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/35227921/

Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/35368376/

Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/35437900/

The impact of psoriasis on the clinical characteristics, disease burden and treatment patterns of peripheral spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35451472/

Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35697486/

Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study (2022)
https://pubmed.ncbi.nlm.nih.gov/35922123/

Elucidating the role of a positive family history in differentiating between axial and peripheral spondyloarthritis: an ancillary analysis of the ASAS-PerSpA study (2022)
https://pubmed.ncbi.nlm.nih.gov/34905484/

Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study (2022)
https://pubmed.ncbi.nlm.nih.gov/35922123/

Deep Learning Detects Changes Indicative of Axial Spondyloarthritis at MRI of Sacroiliac Joints (2022)
https://pubmed.ncbi.nlm.nih.gov/35943339/

Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/36003590/

Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study (2022)
https://pubmed.ncbi.nlm.nih.gov/36003590/

Deep learning for detection of radiographic sacroiliitis: achieving expert-level performance (2021)
https://pubmed.ncbi.nlm.nih.gov/33832519/

Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33796155/

Diagnosing axial spondyloarthritis: estimation of the disease probability in patients with a priori different likelihoods of the diagnosis (2021)
https://pubmed.ncbi.nlm.nih.gov/33693503/

Assessment of radiographic sacroiliitis in anteroposterior lumbar vs conventional pelvic radiographs in axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/32710108/

Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial (2021)
https://pubmed.ncbi.nlm.nih.gov/34785545/

Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis (2021)
https://pubmed.ncbi.nlm.nih.gov/34187873/

Detection of radiographic sacroiliitis with an artificial neural network in patients with suspicion of axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34363456/

Relation of α 2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33317138/

Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa (2020)
https://pubmed.ncbi.nlm.nih.gov/32911279/

Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32447391/

Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31369867/

Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept (2019)
https://pubmed.ncbi.nlm.nih.gov/30625261/

Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/31126334/

Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis? (2017)
https://pubmed.ncbi.nlm.nih.gov/29338611/

Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy (2017)
https://pubmed.ncbi.nlm.nih.gov/28835779/

Study protocol: COmparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of StrUctural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) – an open-label randomized controlled multicenter trial (2017)
https://pubmed.ncbi.nlm.nih.gov/28601821/